T cell immunity rather than antibody mediates cross-protection against Zika virus infection conferred by a live attenuated Japanese encephalitis SA14-14-2 vaccine.



Wang, Ran, Zhen, Zida, Turtle, Lance ORCID: 0000-0002-0778-1693, Hou, Baohua, Li, Yueqi, Wu, Na, Gao, Na, Fan, Dongying, Chen, Hui and An, Jing
(2020) T cell immunity rather than antibody mediates cross-protection against Zika virus infection conferred by a live attenuated Japanese encephalitis SA14-14-2 vaccine. Applied microbiology and biotechnology.

[img] Text
Wang2020_Article_TCellImmunityRatherThanAntibod.pdf - Published Version

Download (1MB) | Preview

Abstract

Zika virus (ZIKV) and Japanese encephalitis virus (JEV) are closely related to mosquito-borne flaviviruses. Japanese encephalitis (JE) vaccine SA14-14-2 has been in the Chinese national Expanded Program on Immunization since 2007. The recent recognition of severe disease syndromes associated with ZIKV, and the identification of ZIKV from mosquitoes in China, prompts an urgent need to investigate the potential interaction between the two. In this study, we showed that SA14-14-2 is protective against ZIKV infection in mice. JE vaccine SA14-14-2 triggered both Th1 and Th2 cross-reactive immune responses to ZIKV; however, it was cellular immunity that predominantly mediated cross-protection against ZIKV infection. Passive transfer of immune sera did not result in significant cross-protection but did mediate antibody-dependent enhancement in vitro, though this did not have an adverse impact on survival. This study suggests that the SA14-14-2 vaccine can protect against ZIKV through a cross-reactive T cell response. This is vital information in terms of ZIKV prevention or precaution in those ZIKV-affected regions where JEV circulates or SA14-14-2 is in widespread use, and opens a promising avenue to develop a novel bivalent vaccine against both ZIKV and JEV. KEY POINTS: • JEV SA14-14-2 vaccine conferred cross-protection against ZIKV challenge in mice. • T cell immunity rather than antibody mediated the cross-protection. • It provides important information in terms of ZIKV prevention or precaution.

Item Type: Article
Uncontrolled Keywords: Japanese encephalitis virus, T cell, SA14-14-2 vaccine, Zika virus, Cross-protection, Corss-reactivity
Depositing User: Symplectic Admin
Date Deposited: 26 Jun 2020 07:58
Last Modified: 05 Aug 2020 10:46
DOI: 10.1007/s00253-020-10710-z
Related URLs:
URI: http://livrepository.liverpool.ac.uk/id/eprint/3091696